insights_auto
Why is EYPT down 4.23%?
Dive Deeperchevron_right
EYPT:NASDAQ
EyePoint Inc
$0.31
arrow_downward
-4.23%(-0.014) 1D
$0.31
arrow_upward
+1.37% (+0.0042)bedtimeAfter hours
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
$0.33
High
$0.33
Low
$0.31
Mkt. cap
26.34M
Avg. vol.
13.56M
Volume
3.09M
52-wk high
$19.11
52-wk low
$0.31
EPS
-$3.96
Beta
1.84
Shares outstanding
86.21M
No. of employees
214
Open
$0.33
High
$0.33
Low
$0.31
Mkt. cap
26.34M
Avg. vol.
13.56M
Volume
3.09M
52-wk high
$19.11
52-wk low
$0.31
EPS
-$3.96
Beta
1.84
Shares outstanding
86.21M
No. of employees
214
News stories
From web sources and news partners
Investing.com
·
16 hours ago
Stifel cuts EyePoint stock price target on trial setbacks
GuruFocus
·
17 hours ago
EYPT Maintained by Stifel -- Price Target Lowered to $5.00
Benzinga
·
1 day ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Yahoo Finance
·
1 day ago
EyePoint Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyePoint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersWatertown, Massachusetts, United States
SectorHealth Care
IndustryPharmaceutical industry
Websiteeyepoint.bio